EARLY RESPONSES IN PATIENT-REPORTED OUTCOMES ARE PREDICTORS FOR MUCOSAL HEALING IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH GOLIMUMAB- RESULTS FROM PURSUIT SC INDUCTION

(1) Centre Hospitalier Universitaire de Lille

(2) Universitätsklinik für Innere Medizin IV

(3) Robarts Research Institute

(4) Janssen R&D, LLC.

(5) Janssen Global Services, LLC.

(6) Alfred Hospital

(7) Oregon Health Sciences University

(8) Orebro University Hospital

(9) 9. University Hospital Gasthuisberg

(10) University of California San Diego



This item was part of the IBD: Therapy beyond anti-TNFs session at UEG Week 2013

This item can be cited as: United European Gastroenterology Journal; 2013: 1 (Supplement 1) A79

Categorisation:

  • Clinical Specialty
    • 'IBD-ology'
  • Diagnosis and Management
    • Medical management
  • Disease
    • Inflammatory bowel disease
  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2013